Serotonergic neurotoxicity of methylenedioxyamphetamine and methylenedioxymetamphetamine.
Monks
T J
TJ
Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, University of Texas at Austin, 78712-1074, USA.
Bai
F
F
Miller
R T
RT
Lau
S S
SS
D015104:3,4-Methylenedioxyamphetamine / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D000111:Acetylcysteine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003846:Deoxyepinephrine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D005978:Glutathione / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D006213:Hallucinogens / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D015394:Molecular Structure; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000378:metabolism; D051381:Rats; D018490:Serotonin Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology
C106085:2,5-bis(glutathionyl)methyldopamine; C460374:5-(N-acetylcystein-S-yl)-alpha-methyldopamine; C096088:5-(glutathion-S-yl)methyldopamine; D006213:Hallucinogens; D018377:Neurotransmitter Agents; D018490:Serotonin Agents; D015104:3,4-Methylenedioxyamphetamine; D005978:Glutathione; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D003846:Deoxyepinephrine; D000111:Acetylcysteine